Heat-induced superaggregation of amphotericin B modifies its interaction with serum proteins and lipoproteins and stimulation of TNF-alpha.
The purpose of the present study was to examine the influence of heat-induced superaggregation of Amphotericin B (AmB) in the Fungizone (FZ) formulation on its interaction with human serum components and relate this to reduced toxicity. Whole serum distribution studies showed that a significantly lower percentage of AmB from HFZ was recovered in the high-density lipoprotein (HDL), low-density lipoprotein (LDL), and triglyceride-rich lipoprotein (TRL) fractions and a greater percentage recovered in the lipoprotein-deficient plasma (LPDP), though the majority of both preparations were recovered in LPDP. Circular dichroism (CD) and difference absorption spectroscopy were used to determine the stability of FZ and heat-treated FZ (HFZ) in the presence of HDL, LDL, serum, and albumin. The CD studies indicate that the "core" aggregate of HFZ is more stable in the presence of HDL and LDL, whereas the FZ is less stable and more dynamic with the core aggregate dissociating to a greater extent in the presence of either purified lipoprotein. Absorption studies with whole serum and purified albumin suggest that FZ aggregates are far less stable in the presence of albumin than HFZ and that interaction with serum albumin is a dominant feature for both drug preparations. HFZ also has a different effect on the cytokine response in vitro. Studies using THP-1 human monocytes show that HFZ provokes a smaller release of tumor necrosis factor (TNF)-alpha than FZ. This cytokine may be associated with the unpleasant side effects of AmB. These findings suggest that heat-induced superaggregation of AmB alters its interaction with HDL, LDL, serum proteins, and monocytes, and these findings may be important in explaining the reduced toxicity of the superaggregated form of AmB.
Hartsel
S C
SC
Department of Chemistry, Phillips Hall, University of Wisconsin-Eau Claire, Eau Claire, Wisconsin 54702-4004, USA. hartsece@uwec.edu
Baas
B
B
Bauer
E
E
Foree
L T
LT
Kindt
K
K
Preis
H
H
Scott
A
A
Kwong
E H
EH
Ramaswamy
M
M
Wasan
K M
KM
D000666:Amphotericin B / Q000737:chemistry* / Q000378:metabolism*; D000935:Antifungal Agents / Q000737:chemistry* / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism*; D002942:Circular Dichroism; D006358:Hot Temperature; D006801:Humans; D008074:Lipoproteins / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*
D000935:Antifungal Agents; D001798:Blood Proteins; D008074:Lipoproteins; D014409:Tumor Necrosis Factor-alpha; D000666:Amphotericin B